Benign Ethnic Neutropenia: An Avoidable Obstacle to Clozapine Use

Joana Romão; Rodrigo Saraiva; Ricardo Coentre

doi:10.20344/amp.24904

Benign Ethnic Neutropenia: An Avoidable Obstacle to Clozapine Use

Authors

Joana Romão Psychiatry and Mental Health Department. Unidade Local de Saúde de Santa Maria. Lisbon. & University Clinic of Psychiatry. Faculdade de Medicina. Universidade de Lisboa. Lisbon. https://orcid.org/0000-0003-3817-1481
Rodrigo Saraiva Psychiatry and Mental Health Department. Unidade Local de Saúde de Santa Maria. Lisbon. & University Clinic of Psychiatry. Faculdade de Medicina. Universidade de Lisboa. Lisbon. https://orcid.org/0000-0003-1344-3612
Ricardo Coentre Psychiatry and Mental Health Department. Unidade Local de Saúde de Santa Maria. Lisbon. & University Clinic of Psychiatry. Faculdade de Medicina. Universidade de Lisboa. Lisbon. https://orcid.org/0000-0002-2939-9436

DOI:

https://doi.org/10.20344/amp.24904

Keywords:

Antipsychotic Agents/adverse effects, Clozapine/adverse effects, Clozapine/therapeutic use, Ethnicity, Neutropenia/chemically induced, Neutropenia/ethnology

Abstract

n/a.

Downloads

Download data is not yet available.

References

Atallah-Yunes SA, Ready A, Newburger PE. Benign ethnic neutropenia. Blood Rev. 2019;37:100586.

Ribeiro ML, Albuquerque S, Saraiva R, Coentre R. Benign ethnic neutropenia and clozapine. Prim Care Companion CNS Disord. 2026;28:25cr04053.

Oloyede E, Casetta C, Dzahini O, Segev A, Gaughran F, Shergill S, et al. Life after the UK clozapine central non-rechallenge database: a national perspective. Schizophr Bull. 2021;47:1088-98.

Wu S, Powell V, Chintoh A, Alarabi M, Agarwal S, Remington G. Safety of BEN guidelines in clozapine treatment: a Canadian perspective. Schizophr Res. 2024;264:451-6.

Downloads

Published

2026-08-03

How to Cite

Romão J, Saraiva R, Coentre R. Benign Ethnic Neutropenia: An Avoidable Obstacle to Clozapine Use. Acta Med Port [Internet]. 2026 Aug. 3 [cited 2026 Aug. 3];39(8):507-8. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/24904

Download Citation

Issue

Vol. 39 No. 8 (2026): August

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.